Name | (+/-)-15-deoxy-16r-hydroxy-17-cyclobutyl prostaglandin e1 |
---|---|
Synonyms |
17,20-Cycloprost-13-en-1-oic acid, 11,16-dihydroxy-9-oxo-17-propyl-, (11α,13E,16S)-
17,20-Cycloprost-13-en-1-oic acid, 11,16-dihydroxy-9-oxo-17-propyl-, (11α,13E,16R)- 9-oxo-11alpha,16s-dihydroxy-17-cyclobutyl-prost-13e-en-1-oic acid Cyclopentaneheptanoic acid, 3-hydroxy-2-[(1E,4R)-4-hydroxy-4-(1-propylcyclobutyl)-1-buten-1-yl]-5-oxo-, (1R,2R,3R)- 9-oxo-11alpha,16r-dihydroxy-17-cyclobutyl-prost-13e-en-1-oic acid 7-{(1R,2R,3R)-3-Hydroxy-2-[(1E,4R)-4-hydroxy-4-(1-propylcyclobutyl)-1-buten-1-yl]-5-oxocyclopentyl}heptanoic acid (11α,13E,16S)-11,16-Dihydroxy-9-oxo-17-propyl-17,20-cycloprost-13-en-1-oic acid (11α,13E,16R)-11,16-Dihydroxy-9-oxo-17-propyl-17,20-cycloprost-13-en-1-oic acid |
Description | (S)-Butaprost (free acid) is a potent and highly selective agonist of EP2 receptor[1]. |
---|---|
Related Catalog | |
Target |
EP2[1] |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 565.7±50.0 °C at 760 mmHg |
Molecular Formula | C23H38O5 |
Molecular Weight | 394.545 |
Flash Point | 310.0±26.6 °C |
Exact Mass | 394.271912 |
PSA | 94.83000 |
LogP | 3.04 |
Vapour Pressure | 0.0±3.5 mmHg at 25°C |
Index of Refraction | 1.558 |